Toxicity Derived from Interaction between Natural Compounds and Cancer Therapeutic Drugs Metabolized by CYP3A4: Lessons Learned from Two Clinical Case Reports
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242115976 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Sabrina Orzetti und 1 weiteren Autor:innen. Beteiligte Einrichtung: PCD Pharmacy Clinical Desk, Hospital Pharmacy Unit of the "Centro di Riferimento Oncologico (CRO) di Aviano IRCCS", Via F. Gallini, 33081 Aviano, Ita…. Hauptthemen laut MEDLINE: Complementary Therapies, Drug-Related Side Effects and Adverse Reactions, Antineoplastic Agents, Biological Products. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute Italiano, Italian Ministry of Health.
Abstract (Originalsprache)
The use of natural compounds and, in general, the use of Complementary and Alternative Medicine (CAM), is growing steadily worldwide, both due to commercial pressure and the increasing use of self-medication and the desire to manage one’s own personal health and well-being. Patients facing a cancer diagnosis are also strongly pressured to use these compounds, which are often added to standard therapeutic regimens, that should instead be based solely on diagnostic and therapeutic care pathways (DTCP) or evidence-based medicine (EBM). This study presents two clinical cases of cancer patients who presented to the pharmaceutical consultation service (PCD—Pharmacy Clinical Desk) established at the CRO Institute in Aviano, Italy. Both patients were using natural products along with prescribed chemotherapy. In the first case, a 55-year-old woman diagnosed with bilateral breast cancer with bone metastases, who was using natural compounds based on diosmin, escin (or aescin) and resveratrol in combination with ribociclib anticancer therapy, a severe ADR (neutropenia) was identified as a consequence of the drug–natural product interaction. In the second case, following a detailed medication review by the PCD, we avoided taking a therapeutic treatment (with natural compounds) that in itself could potentially render chemotherapy ineffective in a 57-year-old woman with multiple infiltrating ductal carcinoma of the left breast; the patient was planning to take a natural product containing St. John’s Wort tincture and lemon balm tincture, in combination with paclitaxel and trastuzumab. In addition, we describe the corrective actions taken, thus outlining the main objectives of the activity of the PCD’s pharmacy counseling service: first, to identify, report, and manage adverse drug reactions (ADRs), and second, to identify therapeutic combinations that present potential risks of toxicity or ineffectiveness of the drug therapy itself.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PCD Pharmacy Clinical Desk, Hospital Pharmacy Unit of the "Centro di Riferimento Oncologico (CRO) di Aviano IRCCS", Via F. Gallini, 33081 Aviano, Italy.
- Hospital Pharmacy Unit of the "Centro di Riferimento Oncologico (CRO) di Aviano IRCCS", Via F. Gallini, 33081 Aviano, Italy.
ORCID-Profile: Sabrina Orzetti, Paolo Baldo
Förderung
- Ministero della Salute Italiano
- Italian Ministry of Health
Zitieren
APA
Orzetti, S., & Baldo, P. (2023). Toxicity Derived from Interaction between Natural Compounds and Cancer Therapeutic Drugs Metabolized by CYP3A4: Lessons Learned from Two Clinical Case Reports. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115976
Vancouver
Orzetti S, Baldo P. Toxicity Derived from Interaction between Natural Compounds and Cancer Therapeutic Drugs Metabolized by CYP3A4: Lessons Learned from Two Clinical Case Reports. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115976
BibTeX
@article{Orzetti2023,
author = {Orzetti, Sabrina and Baldo, Paolo},
title = {Toxicity Derived from Interaction between Natural Compounds and Cancer Therapeutic Drugs Metabolized by CYP3A4: Lessons Learned from Two Clinical Case Reports},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242115976}
}
EUVIMED